STEGLATRO (Ertugliflozin) - Pills

STEGLATRO (Ertugliflozin) is a name-brand medication formulated to help individuals with type 2 diabetes more effectively manage their blood sugar levels. As an integral part of a comprehensive treatment plan, STEGLATRO, when used with a balanced diet and regular exercise, can significantly lower blood sugar levels and contribute to better overall health for those living with this prevalent condition. Ertugliflozin, the active ingredient in STEGLATRO, is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that reduces the amount of sugar reabsorbed by the kidneys and promotes its excretion through urine. This process helps to lower blood sugar levels in individuals with type 2 diabetes, a condition characterized by high blood sugar due to the body's inability to produce or utilize insulin effectively. In some cases, STEGLATRO may be combined with other medications to optimize blood sugar control further and enhance the overall effectiveness of a patient's treatment plan. When taking STEGLATRO, following your healthcare provider's recommendations for proper dosage and administration is essential to ensure the medication's effectiveness and safety. As with any drug, potential side effects may occur, including dehydration, urinary tract infections, or dizziness. It is crucial to discuss any concerns or symptoms with your healthcare provider to address and manage any potential issues promptly. By incorporating STEGLATRO into your type 2 diabetes management strategy, you can experience improved blood sugar control, better overall health, and enhanced quality of life.